Ex-CVS Exec Probed On Drug Prices In Overcharge Trial

By Dorothy Atkins · June 11, 2021, 10:11 PM EDT

A former CVS Pharmacy executive conceded to a California federal jury trial Friday that the chain didn't report its discounted drug prices to pharmacy benefit managers to avoid losing about $500 million...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Case Information

Case Title

Carl Washington et al v. CVS Pharmacy Inc.

Case Number

Court

California Northern

Nature of Suit

Other Fraud

Date Filed

July 30, 2015

Recent Articles By Dorothy

November 01, 2024
Elevance Says Flawed Medicare Rating System Cost It $375M
October 04, 2024
NJ, Ethics Board Must Hand Over Docs In Retaliation Fight
August 30, 2024
Align Tech Cuts $27.5M Antitrust Deal With 1.45M Consumers
August 29, 2024
Sutter Health Kickback Fight Likely Headed To Nov. Trial
August 23, 2024
Ohio Constitution Dooms 24-Hour Abortion Waiting Period
August 21, 2024
Tobacco Cos. Ask Justices To Review FDA's New Warnings
August 13, 2024
Janssen Wants New FCA Trial As Relators Seek $1.85B Win
August 09, 2024
Split 9th Circ. Affirms Ax Of Meta Anti-Vax Censorship Suit
August 05, 2024
Fla. Man Gets 44 Months For $5M MilliporeSigma Export Scam
July 18, 2024
Abbott Wins Trust Asset Freeze To Collect $33M In TM Fight